Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | 10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2024 | mrk-20241231.htm iXBRL | 10-K | 5027463 |
| 2 | EX-4.11 DESCRIPTION OF SECURITIES | exh411-descriptionofsecuri.htm | EX-4.11 | 261121 |
| 3 | EX-10.1 EXECUTIVE INCENTIVE PLAN | exh101-eipplan.htm | EX-10.1 | 52585 |
| 4 | EX-10.13 MERCK & CO., INC. U.S. SEPARATION BENEFITS PLAN | exh1013-mrkseparationplan2.htm | EX-10.13 | 1878617 |
| 5 | EX-10.31 2024 ANNUAL RSU TERMS & CONDITIONS | exh1031-2024annualrsuterms.htm | EX-10.31 | 377195 |
| 6 | EX-10.32 2024 ANNUAL PSU TERMS & CONDITIONS | exh1032-2024annualpsuterms.htm | EX-10.32 | 544084 |
| 7 | EX-10.33 2024 ANNUAL NQSO TERMS & CONDITIONS | exh1033-2024annualnqsoterm.htm | EX-10.33 | 186652 |
| 8 | EX-10.34 2024 SPECIAL RETENTION RSU TERMS & CONDITIONS | exh1034-2024specialretenti.htm | EX-10.34 | 83970 |
| 9 | EX-10.35 OFFER LETTER (LARSON) | exh1035-bettylarsonofferle.htm | EX-10.35 | 64381 |
| 10 | EX-10.36 2024 ANNUAL RSU SIGN-ON TERMS & CONDITIONS (LARSON) | exh1036-2024annualrsusignx.htm | EX-10.36 | 87452 |
| 11 | EX-19 INSIDER TRADING POLICY | exh19-insidertradingpolicy.htm | EX-19 | 22558 |
| 12 | EX-21 SUBSIDIARY LIST | exh21-subsidiarylistasof12.htm | EX-21 | 276395 |
| 13 | EX-23 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | exh23-consentofindependent.htm | EX-23 | 2323 |
| 14 | EX-24.1 POWER OF ATTORNEY | exh241-powerofattorney.htm | EX-24.1 | 15205 |
| 15 | EX-24.2 CERTIFICATION OF BOARD RESOLUTION | exh242-certificationofboar.htm | EX-24.2 | 6759 |
| 16 | EX-31.1 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CEO | exh311-rule13ax14a15dx14ac.htm | EX-31.1 | 8068 |
| 17 | EX-31.2 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CFO | exh312-rule13ax14a15dx14ac.htm | EX-31.2 | 8103 |
| 18 | EX-32.1 SECTION 1350 CERTIFICATION OF CEO | exh321-section1350certific.htm | EX-32.1 | 4057 |
| 19 | EX-32.2 SECTION 1350 CERTIFICATION OF CFO | exh322-section1350certific.htm | EX-32.2 | 3662 |
| 25 | exhibitcover.jpg | GRAPHIC | 348105 | |
| 26 | image_10.jpg | GRAPHIC | 3105 | |
| 27 | image_6.jpg | GRAPHIC | 34787 | |
| 28 | image_8x1.jpg | GRAPHIC | 7990 | |
| 29 | image_9.jpg | GRAPHIC | 6136 | |
| 30 | logo.jpg | GRAPHIC | 6373 | |
| 31 | mrk-20241231_g1.jpg | GRAPHIC | 137767 | |
| 32 | mrk-20241231_g2.jpg | GRAPHIC | 81788 | |
| 33 | mrk-20241231_g3.jpg | GRAPHIC | 28639 | |
| 34 | mrk-20241231_g4.jpg | GRAPHIC | 24577 | |
| 35 | mrk-20241231_g5.jpg | GRAPHIC | 24326 | |
| 36 | mrk-20241231_g6.jpg | GRAPHIC | 26041 | |
| 37 | mrk-20241231_g7.gif | GRAPHIC | 5605 | |
| 38 | mrk-20241231_g8.jpg | GRAPHIC | 31485 | |
| 39 | mrk-20241231_g9.jpg | GRAPHIC | 17845 | |
| 40 | picture1.jpg | GRAPHIC | 4032 | |
| Complete submission text file | 0001628280-25-007732.txt | 31592793 |
Data Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 20 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mrk-20241231.xsd | EX-101.SCH | 130598 |
| 21 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mrk-20241231_cal.xml | EX-101.CAL | 161739 |
| 22 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mrk-20241231_def.xml | EX-101.DEF | 878153 |
| 23 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mrk-20241231_lab.xml | EX-101.LAB | 1483678 |
| 24 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mrk-20241231_pre.xml | EX-101.PRE | 1216944 |
| 174 | EXTRACTED XBRL INSTANCE DOCUMENT | mrk-20241231_htm.xml | XML | 5843465 |
EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-06571 | Film No.: 25663539
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)
